-
1
-
-
45149125575
-
Site-specific linking of biomolecules via glycan residues using glycosyltransferases
-
Qasba PK, Boeggeman E Ramakrishnan B. Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Progr 2008; 24: 520-526. doi: 10.1021/bp0704034
-
(2008)
Biotechnol Progr
, vol.24
, pp. 520-526
-
-
Qasba, P.K.1
Boeggeman, B.2
Ramakrishnan, E.3
-
2
-
-
44449153943
-
Functional roles of N-glycans in cell signaling and cell adhesion in cancer
-
Zhao YY, Takahashi M, Gu JG, et al. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 2008; 99: 13041310. doi: 10.1111/j.1349-7006.2008.00839.x
-
(2008)
Cancer Sci
, vol.99
, pp. 1304-1310
-
-
Zhao, Y.Y.1
Takahashi, M.2
Gu, J.G.3
-
3
-
-
84901241878
-
Emerging trends in hepatocellular carcinoma: Focus on diagnosis and therapeutics
-
Flores A, Marrero JA. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics. Clin Med Insights Oncol 2014; 8: 71. doi: 10.4137/CMO.S9926
-
(2014)
Clin Med Insights Oncol
, vol.8
, pp. 71
-
-
Flores, A.1
Marrero, J.A.2
-
4
-
-
0034092856
-
Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting
-
Muramatsu T. Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting. J Biochem 2000; 127: 171-176.
-
(2000)
J Biochem
, vol.127
, pp. 171-176
-
-
Muramatsu, T.1
-
5
-
-
84892805731
-
Cancer statistics, 2014
-
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29. doi: 10.3322/caac.21208
-
(2014)
CA Cancer J Clin
, vol.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
6
-
-
84907513085
-
Hepatocellular carcinoma: Systemic therapies and future perspectives
-
Mikhail S, Cosgrove D, Zeidan A. Hepatocellular carcinoma: systemic therapies and future perspectives. Expert Rev Anticancer Ther 2014; 14: 1205-1218. doi: 10.1586/14737140.2014.949246
-
(2014)
Expert Rev Anticancer Ther
, vol.14
, pp. 1205-1218
-
-
Mikhail, S.1
Cosgrove, D.2
Zeidan, A.3
-
7
-
-
70449717008
-
Challenge and hope in radiotherapy of hepatocellular carcinoma
-
Seong J. Challenge and hope in radiotherapy of hepatocellular carcinoma. Yonsei Med J 2009; 50: 601-612. doi: 10.3349/ymj.2009.50.5.601
-
(2009)
Yonsei Med J
, vol.50
, pp. 601-612
-
-
Seong, J.1
-
9
-
-
84920989984
-
Long-term culture of genomestable bipotent stem cells from adult human liver
-
Huch M, Gehart G, van Boxtel R, et al. Long-term culture of genomestable bipotent stem cells from adult human liver. Cell 2015; 160: 299312. doi: 10.1016/j.cell.2014.11.050
-
(2015)
Cell
, vol.160
, pp. 299-312
-
-
Huch, M.1
Gehart, G.2
Van Boxtel, R.3
-
10
-
-
66149109566
-
Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury
-
Van Hul NK, Abarca-Quinones J, Sempoux C, Horsmans Y, Leclercq IA. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 2009; 49: 1625-1635. doi: 10.1002/hep.22820
-
(2009)
Hepatology
, vol.49
, pp. 1625-1635
-
-
Van Hul, N.K.1
Abarca-Quinones, J.2
Sempoux, C.3
Horsmans, Y.4
Leclercq, I.A.5
-
11
-
-
40749150740
-
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/ PKB survival pathway
-
Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/ PKB survival pathway. Oncogene 2008; 27: 1749-1758. doi: 10.1038/ sj.onc.1210811
-
(2008)
Oncogene
, vol.27
, pp. 1749-1758
-
-
Ma, S.1
Lee, T.K.2
Zheng, B.J.3
Chan, K.W.4
Guan, X.Y.5
-
12
-
-
84872167512
-
Human liver stem cells improve liver injury in a model of fulminant liver failure
-
Herrera MB, Fonsato V, Bruno S, et al. Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 2013; 57: 311-319. doi: 10.1002/hep.25986
-
(2013)
Hepatology
, vol.57
, pp. 311-319
-
-
Herrera, M.B.1
Fonsato, V.2
Bruno, S.3
-
13
-
-
71149086704
-
The quest for liver progenitor cells: A practical point of view
-
Dollé L, Best J, Mei J, et al. The quest for liver progenitor cells: a practical point of view. J Hepatol 2010; 52: 117-129. doi: 10.1016/j. jhep.2009.10.009
-
(2010)
J Hepatol
, vol.52
, pp. 117-129
-
-
Dollé, L.1
Best, J.2
Mei, J.3
-
14
-
-
33746441453
-
Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors
-
Zender L, Xue W, Cordon-Cardo C, et al. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harb Symp Quant Biol 2005; 70: 251-261. doi: 10.1101/sqb.2005.70.059
-
(2005)
Cold Spring Harb Symp Quant Biol
, vol.70
, pp. 251-261
-
-
Zender, L.1
Xue, W.2
Cordon-Cardo, C.3
-
15
-
-
22544450728
-
Transformation of human and murine fibroblasts without viral oncoproteins
-
Boehm JS, Hession MT, Bulmer SE, Hahn WC. Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol 2005; 25: 6464-6474. doi: 10.1128/MCB.25.15.6464-6474.2005
-
(2005)
Mol Cell Biol
, vol.25
, pp. 6464-6474
-
-
Boehm, J.S.1
Hession, M.T.2
Bulmer, S.E.3
Hahn, W.C.4
-
16
-
-
1642309129
-
Glycosylation defining cancer cell motility and invasiveness
-
Ono M, Hakomori S. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J 2004; 20: 71-78. doi: 10.1023/B:GLYC.00000 18019.22070.7d
-
(2004)
Glycoconj J
, vol.20
, pp. 71-78
-
-
Ono, M.1
Hakomori, S.2
-
19
-
-
1342306245
-
Biases and complex patterns in the residues flanking protein N-glycosylation sites
-
Ben-Dor S, Esterman N, Rubin E, Sharon N. Biases and complex patterns in the residues flanking protein N-glycosylation sites. Glycobiology 2004; 14: 95-101. doi: 10.1093/glycob/cwh004
-
(2004)
Glycobiology
, vol.14
, pp. 95-101
-
-
Ben-Dor, S.1
Esterman, N.2
Rubin, E.3
Sharon, N.4
-
20
-
-
33644830438
-
Role of N-and O-glycans in polarized biosynthetic sorting
-
Potter BA, Hughey RP, Weisz OA. Role of N-and O-glycans in polarized biosynthetic sorting. Am J Physiol Cell Physiol 2006; 290: C1-C10. doi: 10.1152/ajpcell.00333.2005
-
(2006)
Am J Physiol Cell Physiol
, vol.290
, pp. CC1-C10
-
-
Potter, B.A.1
Hughey, R.P.2
Weisz, O.A.3
-
21
-
-
80053469048
-
Mechanisms and principles of N-linked protein glycosylation
-
Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struc Biol 2011; 21: 576-582. doi: 10.1016/j. sbi.2011.08.005
-
(2011)
Curr Opin Struc Biol
, vol.21
, pp. 576-582
-
-
Schwarz, F.1
Aebi, M.2
-
22
-
-
84856098171
-
Role of mucus layers in gut infection and inflammation
-
Hansson GC. Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol 2012; 15: 57-62. doi: 10.1016/j.mib.2011.11.002
-
(2012)
Curr Opin Microbiol
, vol.15
, pp. 57-62
-
-
Hansson, G.C.1
-
23
-
-
0037234565
-
All in the family: The UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferases
-
Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 2003; 13: 1R-16R. doi: 10.1093/glycob/cwg007
-
(2003)
Glycobiology
, vol.13
, pp. 1RR-16R
-
-
Ten Hagen, K.G.1
Fritz, T.A.2
Tabak, L.A.3
-
24
-
-
0035146448
-
Database analysis of O-glycosylation sites in proteins
-
Christlet THT, Veluraja K. Database analysis of O-glycosylation sites in proteins. Biophys J 2001; 80: 952-960. doi: 10.1016/S00063495(01)76074-2
-
(2001)
Biophys J
, vol.80
, pp. 952-960
-
-
Christlet, T.1
Veluraja, K.2
-
25
-
-
0028179379
-
UDPgalactose: Glycoprotein–Nacetyl-d-galactosamine 3-ß-d-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates
-
Granovsky M, Bielfeldt T, Peters S, et al. UDPgalactose: glycoprotein–Nacetyl-d-galactosamine 3-ß-d-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates. Eur J Biochem 1994; 221: 1039-1046. doi: 10.1111/j.1432-1033.1994.tb18822.x
-
(1994)
Eur J Biochem
, vol.221
, pp. 1039-1046
-
-
Granovsky, M.1
Bielfeldt, T.2
Peters, S.3
-
26
-
-
0009620955
-
Common antigenic determinants in the glycoproteins of plants, molluscs and insects
-
Faye L, Chrispeels MJ. Common antigenic determinants in the glycoproteins of plants, molluscs and insects. Glycoconj J 1988; 5: 245256. doi: 10.1007/BF01049085
-
(1988)
Glycoconj J
, vol.5
, pp. 245-256
-
-
Faye, L.1
Chrispeels, M.J.2
-
27
-
-
79960720473
-
Glycosylation, galectins and cellular signaling
-
Boscher C, Dennis JW, Nabi IR. Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol 2011; 23: 383-392. doi: 10.1016/j. ceb.2011.05.001
-
(2011)
Curr Opin Cell Biol
, vol.23
, pp. 383-392
-
-
Boscher, C.1
Dennis, J.W.2
Nabi, I.R.3
-
28
-
-
34447558236
-
ER chaperones in mammalian development and human diseases
-
Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett 2007; 581: 3641-3651. doi: 10.1016/j. febslet.2007.04.045
-
(2007)
FEBS Lett
, vol.581
, pp. 3641-3651
-
-
Ni, M.1
Lee, A.S.2
-
29
-
-
0034061923
-
Suppression of tumor growth and metastasis in Mgat5-deficient mice
-
Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 2000; 6: 306-312. doi: 10.1038/73163
-
(2000)
Nat Med
, vol.6
, pp. 306-312
-
-
Granovsky, M.1
Fata, J.2
Pawling, J.3
Muller, W.J.4
Khokha, R.5
Dennis, J.W.6
-
30
-
-
0030797268
-
Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide ß (1, 6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential
-
Pierce M, Buckhaults P, Chen L, Fregien N. Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide ß (1, 6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 1997; 14: 623-630. doi: 10.1023/A:1018592627696
-
(1997)
Glycoconj J
, vol.14
, pp. 623-630
-
-
Pierce, M.1
Buckhaults, P.2
Chen, L.3
Fregien, N.4
-
31
-
-
0024255643
-
Structural changes induced in the sugar chains of glycoproteins by malignant transformation of producing cells and their clinical application
-
Kobata A. Structural changes induced in the sugar chains of glycoproteins by malignant transformation of producing cells and their clinical application. Biochimie 1988; 70: 1575-1585. doi: 10.1016/03009084(88)90293-3
-
(1988)
Biochimie
, vol.70
, pp. 1575-1585
-
-
Kobata, A.1
-
32
-
-
6044239186
-
Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis
-
Partridge EA, Le Roy C, Di Guglielmo GM, et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004; 206: 120-124. doi: 10.1126/science.1102109
-
(2004)
Science
, vol.206
, pp. 120-124
-
-
Partridge, E.A.1
Le Roy, C.2
Di Guglielmo, G.M.3
-
33
-
-
0032558738
-
The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products
-
Chen L, Zhang W, Fregien N, Pierce M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 1998; 17: 2087-2093. doi: 10.1038/sj.onc.1202124
-
(1998)
Oncogene
, vol.17
, pp. 2087-2093
-
-
Chen, L.1
Zhang, W.2
Fregien, N.3
Pierce, M.4
-
34
-
-
0034099208
-
Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways
-
Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000; 15: 357-368. doi: 10.1046/j.14401746.2000.02069.x
-
(2000)
J Gastroenterol Hepatol
, vol.15
, pp. 357-368
-
-
Arbuthnot, P.1
Capovilla, A.2
Kew, M.3
-
35
-
-
55549103319
-
Identification of ß-1, 4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell
-
Wei Y, Liu D, Zhou F, et al. Identification of ß-1, 4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell. J Hepatol 2008; 49: 1029-1037. doi: 10.1016/j.jhep.2008.09.003
-
(2008)
J Hepatol
, vol.49
, pp. 1029-1037
-
-
Wei, Y.1
Liu, D.2
Zhou, F.3
-
36
-
-
0034657712
-
Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation
-
Parodi A. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J 2000; 348: 1-13. doi: 10.1042/bj3480001
-
(2000)
Biochem J
, vol.348
, pp. 1-13
-
-
Parodi, A.1
-
37
-
-
79959396378
-
Fucosylation and gastrointestinal cancer
-
Moriwaki K, Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol 2010; 2: 151-161. doi: 10.4254/wjh.v2.i4.151
-
(2010)
World J Hepatol
, vol.2
, pp. 151-161
-
-
Moriwaki, K.1
Miyoshi, E.2
-
38
-
-
46349088505
-
Biological function of fucosylation in cancer biology
-
Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008; 143: 725-729. doi: 10.1093/jb/ mvn011
-
(2008)
J Biochem
, vol.143
, pp. 725-729
-
-
Miyoshi, E.1
Moriwaki, K.2
Nakagawa, T.3
-
39
-
-
84876697786
-
Expression of alpha 1, 6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression
-
Ji J, Gu X, Fang M, Zhao Y, Yi C, Wang A, Gao C. Expression of alpha 1, 6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression. Dig Liver Dis 2013; 45: 414-421. doi: 10.1016/j.dld.2012.12.007
-
(2013)
Dig Liver Dis
, vol.45
, pp. 414-421
-
-
Ji, J.1
Gu, X.2
Fang, M.3
Zhao, Y.4
Yi, C.5
Wang, A.6
Gao, C.7
-
40
-
-
0141919565
-
Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines
-
Noda K, Miyoshi E, Gu J, et al. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res 2003; 63: 6282-6289.
-
(2003)
Cancer Res
, vol.63
, pp. 6282-6289
-
-
Noda, K.1
Miyoshi, E.2
Gu, J.3
-
41
-
-
70449970103
-
Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers
-
Dai Z, Zhou J, Qiu S, Liu YK, Fan J. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis 2009; 30: 2957–2966. doi: 10.1002/ elps.200900064
-
(2009)
Electrophoresis
, vol.30
, pp. 2957-2966
-
-
Dai, Z.1
Zhou, J.2
Qiu, S.3
Liu, Y.K.4
Fan, J.5
-
42
-
-
36348983813
-
N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus
-
Liu XE, Desmyter K, Gao CF, et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007; 46: 1426-1435. doi: 10.1002/hep.21855
-
(2007)
Hepatology
, vol.46
, pp. 1426-1435
-
-
Liu, X.E.1
Desmyter, K.2
Gao, C.F.3
-
44
-
-
84862919698
-
Glycan-related gene expression signatures in human metastatic hepatocellular carcinoma cells
-
Kang X, Wang N, Pei C, et al. Glycan-related gene expression signatures in human metastatic hepatocellular carcinoma cells. Exp Ther Med 2012; 3: 415-422. doi: 10.3892/etm.2011.430
-
(2012)
Exp Ther Med
, vol.3
, pp. 415-422
-
-
Kang, X.1
Wang, N.2
Pei, C.3
-
45
-
-
84876012263
-
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines
-
Swindall AF, Londono-Joshi AI, Schultz MJ, Fineberg N, Buchsbaum DJ, Bellis SL. ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Res 2013; 73: 2368-2378. doi: 10.1158/0008-5472.CAN-12-3424
-
(2013)
Cancer Res
, vol.73
, pp. 2368-2378
-
-
Swindall, A.F.1
Londono-Joshi, A.I.2
Schultz, M.J.3
Fineberg, N.4
Buchsbaum, D.J.5
Bellis, S.L.6
-
46
-
-
0037470066
-
The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin1-induced CD45 clustering, phosphatase modulation, and T cell death
-
Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin1-induced CD45 clustering, phosphatase modulation, and T cell death. J Biol Chem 2003; 278: 7469-7475. doi: 10.1074/jbc.M209595200
-
(2003)
J Biol Chem
, vol.278
, pp. 7469-7475
-
-
Amano, M.1
Galvan, M.2
He, J.3
Baum, L.G.4
-
47
-
-
0035978521
-
Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro
-
Zhu Y, Srivatana U, Ullah A, et al. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 2001; 1536: 148-160. doi: 10.1016/S09254439(01)00044-8
-
(2001)
Biochim Biophys Acta
, vol.1536
, pp. 148-160
-
-
Zhu, Y.1
Srivatana, U.2
Ullah, A.3
-
48
-
-
0037136406
-
Oligosaccharide specificity of galectins: A search by frontal affinity chromatography
-
Hirabayashi J, Hashidate T, Arata Y, et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 2002; 1572: 232-254. doi: 10.1016/S0304-4165(02)00311-2
-
(2002)
Biochim Biophys Acta
, vol.1572
, pp. 232-254
-
-
Hirabayashi, J.1
Hashidate, T.2
Arata, Y.3
-
49
-
-
0742306881
-
Expression of ß-galactoside a2, 6 sialyltransferase and of a2, 6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis
-
Dall’Olio F, Chiricolo M, D’Errico A, et al. Expression of ß-galactoside a2, 6 sialyltransferase and of a2, 6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology 2004; 14: 39-49. doi: 10.1093/glycob/cwh002
-
(2004)
Glycobiology
, vol.14
, pp. 39-49
-
-
Dall’Olio, F.1
Chiricolo, M.2
D’Errico, A.3
-
50
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. doi: 10.1016/j. stem.2007.08.014
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
-
51
-
-
77954019973
-
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
-
Yang XR, Xu Y, Yu B, et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 2010; 59: 953-962. doi: 10.1136/gut.2008.176271
-
(2010)
Gut
, vol.59
, pp. 953-962
-
-
Yang, X.R.1
Xu, Y.2
Yu, B.3
-
52
-
-
84890129382
-
Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues
-
Zhu J, Wang Y, Yu Y, et al. Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues. Liver Int 2014; 34: 147-160. doi: 10.1111/liv.12265
-
(2014)
Liver Int
, vol.34
, pp. 147-160
-
-
Zhu, J.1
Wang, Y.2
Yu, Y.3
-
53
-
-
33747495216
-
Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma
-
Ho JC, Cheung ST, Patil M, Chen X, Fan ST. Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma. Int J Cancer 2006; 119: 1330-1337. doi: 10.1002/ijc.22005
-
(2006)
Int J Cancer
, vol.119
, pp. 1330-1337
-
-
Ho, J.C.1
Cheung, S.T.2
Patil, M.3
Chen, X.4
Fan, S.T.5
-
54
-
-
80053300659
-
Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma
-
Jia D, Wei L, Guo W, et al. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology 2011; 54: 1227-1236. doi: 10.1002/hep.24495
-
(2011)
Hepatology
, vol.54
, pp. 1227-1236
-
-
Jia, D.1
Wei, L.2
Guo, W.3
-
55
-
-
0034084194
-
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein
-
Mita Y, Aoyagi Y, Suda T, Asakura H. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein. J Hepatol 2000; 32: 946-954. doi: 10.1016/S0168-8278(00)80099-9
-
(2000)
J Hepatol
, vol.32
, pp. 946-954
-
-
Mita, Y.1
Aoyagi, Y.2
Suda, T.3
Asakura, H.4
-
56
-
-
0034749063
-
AFP-L3: A new generation of tumor marker for hepatocellular carcinoma
-
Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 2001; 313: 15-19. doi: 10.1016/S0009-8981(01)00644-1
-
(2001)
Clin Chim Acta
, vol.313
, pp. 15-19
-
-
Li, D.1
Mallory, T.2
Satomura, S.3
-
57
-
-
0035668456
-
A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma
-
Steel LF, Mattu TS, Mehta A, et al. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers 2001; 17: 179-189. doi: 10.1155/2001/963023
-
(2001)
Dis Markers
, vol.17
, pp. 179-189
-
-
Steel, L.F.1
Mattu, T.S.2
Mehta, A.3
-
58
-
-
63549111877
-
Detection of hepatocellular carcinoma using glycomic analysis
-
Goldman R, Ressom HW, Varghese RS, et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 2009; 15: 18081813. doi: 10.1158/1078-0432.CCR-07-5261
-
(1813)
Clin Cancer Res
, vol.15
, Issue.1808
, pp. 2009
-
-
Goldman, R.1
Ressom, H.W.2
Varghese, R.S.3
-
59
-
-
0035143883
-
Screening for cancer in viral hepatitis
-
Colombo M. Screening for cancer in viral hepatitis. Clin Liver Dis 2001; 5: 109-122. doi: 10.1016/S1089-3261(05)70156-2
-
(2001)
Clin Liver Dis
, vol.5
, pp. 109-122
-
-
Colombo, M.1
-
60
-
-
0038482034
-
Test characteristics of a-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis CA systematic review and critical analysis
-
Gupta S, Bent S, Kohlwes J. Test characteristics of a-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis CA systematic review and critical analysis. Ann Intern Med 2003; 139: 46-50. doi: 10.7326/0003-4819-139-1-200307010-00012
-
(2003)
Ann Intern Med
, vol.139
, pp. 46-50
-
-
Gupta, S.1
Bent, S.2
Kohlwes, J.3
-
61
-
-
33748745740
-
Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: Tissue microarray analysis of immunohistochemical scores with clinicopathological parameters
-
Tsai WC, Chao YC, Lee WH, Chen A, Sheu LF, Jin JS. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology 2006; 49: 388-395. doi: 10.1111/j.1365-2559.2006.02516.x
-
(2006)
Histopathology
, vol.49
, pp. 388-395
-
-
Tsai, W.C.1
Chao, Y.C.2
Lee, W.H.3
Chen, A.4
Sheu, L.F.5
Jin, J.S.6
-
62
-
-
0035266353
-
Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions
-
Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001; 61: 2276-2281.
-
(2001)
Cancer Res
, vol.61
, pp. 2276-2281
-
-
Sun, J.1
Hemler, M.E.2
-
64
-
-
84875917629
-
CD147/EMMPRIN: An effective therapeutic target for hepatocellular carcinoma
-
Tang X, Guo N, Xu L, Gou X, Mi M. CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma. J Drug Target 2013; 21: 224-231. doi: 10.3109/1061186X.2012.702769
-
(2013)
J Drug Target
, vol.21
, pp. 224-231
-
-
Tang, X.1
Guo, N.2
Xu, L.3
Gou, X.4
Mi, M.5
-
65
-
-
84880418726
-
Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma
-
Zhu XW, Gong JP. Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma. Asian Pac J Cancer Prev 2013; 14: 1579-1583. doi: 10.7314/APJCP.2013.14.3.1579
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 1579-1583
-
-
Zhu, X.W.1
Gong, J.P.2
-
66
-
-
84886266186
-
Tissue factor pathway inhibitor-2 silencing promotes hepatocellular carcinoma cell invasion in vitro
-
Zhu B, Zhang P, Zeng P, et al. Tissue factor pathway inhibitor-2 silencing promotes hepatocellular carcinoma cell invasion in vitro. Anat Rec 2013; 296: 1708-1716. doi: 10.1002/ar.22789
-
(2013)
Anat Rec
, vol.296
, pp. 1708-1716
-
-
Zhu, B.1
Zhang, P.2
Zeng, P.3
-
67
-
-
0034893404
-
Hepatocellular carcinoma-cause, treatment and metastasis
-
Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454.
-
(2001)
World J Gastroenterol
, vol.7
, pp. 445-454
-
-
Tang, Z.Y.1
-
68
-
-
84889594198
-
MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells
-
Liu X, Chen Q, Yan J, et al. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells. Cell Death Dis 2013; 4: 928. doi: 10.1038/cddis.2013.458
-
(2013)
Cell Death Dis
, vol.4
, pp. 928
-
-
Liu, X.1
Chen, Q.2
Yan, J.3
-
69
-
-
0035698304
-
N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma
-
Yanagi M Aoyagi Y, Suda T, et al. N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2001; 16: 1282-1289. doi: 10.1046/j.1440-1746.2001.02612.x
-
(2001)
J Gastroenterol Hepatol
, vol.16
, pp. 1282-1289
-
-
Yanagi M Aoyagi, Y.1
Suda, T.2
-
70
-
-
84896774734
-
Cell surface protein glycosylation in cancer
-
Christiansen MN, Chik J, Lee L, Anugraham M, Abrahams JL, Packer NH. Cell surface protein glycosylation in cancer. Proteomics 2014; 14: 525-546. doi: 10.1002/pmic.201300387
-
(2014)
Proteomics
, vol.14
, pp. 525-546
-
-
Christiansen, M.N.1
Chik, J.2
Lee, L.3
Anugraham, M.4
Abrahams, J.L.5
Packer, N.H.6
-
71
-
-
0026446025
-
Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma
-
Hiraizumi S, Takasaki S, Ohuchi N, et al. Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma. Cancer Sci 1992; 83: 1063-1072. doi: 10.1111/j.1349-7006.1992. tb02723.x
-
(1992)
Cancer Sci
, vol.83
, pp. 1063-1072
-
-
Hiraizumi, S.1
Takasaki, S.2
Ohuchi, N.3
-
72
-
-
20044377211
-
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans
-
Block TM, Communale, MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 2005; 102: 779-784. doi: 10.1073/pnas.0408928102
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 779-784
-
-
Block, T.M.1
Communale, M.A.2
Lowman, M.3
-
73
-
-
84925283673
-
Diagnostic value of alphafetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels
-
Xu WJ, Guo BL, Han YG, Shi L, Ma WS. Diagnostic value of alphafetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels. Tumour Biol 2014; 35: 12069-12074. doi: 10.1007/ s13277-014-2506-8
-
(2014)
Tumour Biol
, vol.35
, pp. 12069-12074
-
-
Xu, W.J.1
Guo, B.L.2
Han, Y.G.3
Shi, L.4
Ma, W.S.5
-
74
-
-
33750620940
-
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers
-
Drake RR, Schwegler EE, Malik G, et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics 2006; 5: 1957-1967. doi: 10.1074/mcp.M600176-MCP200
-
(2006)
Mol Cell Proteomics
, vol.5
, pp. 1957-1967
-
-
Drake, R.R.1
Schwegler, E.E.2
Malik, G.3
-
75
-
-
84904479786
-
The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors
-
Bröker ME, Ijzermans JN, Witjes CD, van Vuuren HJ, de Man RA. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors. PloS One 2014; 9: e100187. doi: 10.1371/journal. pone.0100187
-
(2014)
Plos One
, vol.9
-
-
Bröker, M.E.1
Ijzermans, J.N.2
Witjes, C.D.3
Van Vuuren, H.J.4
De Man, R.A.5
-
76
-
-
34948905277
-
Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzenesulfenyl (NBS) stable isotope labeling: A new approach for the novel biomarker discovery for cancer
-
Ueda K, Katagiri T, Shimada T, et al. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzenesulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res 2007; 6: 3475-3483. doi: 10.1021/pr070103h
-
(2007)
J Proteome Res
, vol.6
, pp. 3475-3483
-
-
Ueda, K.1
Katagiri, T.2
Shimada, T.3
-
77
-
-
84902089821
-
Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies
-
Zhu J, Lin Z, Wu J, et al. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res 2014; 13: 2986–2997. doi: 10.1021/pr500128t
-
(2014)
J Proteome Res
, vol.13
, pp. 2986-2997
-
-
Zhu, J.1
Lin, Z.2
Wu, J.3
-
78
-
-
78149304332
-
Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein
-
Shu H, Kang X, Guo K, et al. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein. Oncol Rep 2010; 24: 1271-1276. doi: 10.3892/ or_00000982
-
(2010)
Oncol Rep
, vol.24
, pp. 1271-1276
-
-
Shu, H.1
Kang, X.2
Guo, K.3
-
79
-
-
79954497042
-
N-linked glycan changes of serum haptoglobin ß chain in liver disease patients
-
Zhang S, Shu H, Luo K, et al. N-linked glycan changes of serum haptoglobin ß chain in liver disease patients. Mol Biosyst 2011; 7: 16211628. doi: 10.1039/c1mb05020f
-
(1628)
Mol Biosyst
, vol.7
, Issue.1621
, pp. 2011
-
-
Zhang, S.1
Shu, H.2
Luo, K.3
-
80
-
-
84915746070
-
Protein and site specificity of fucosylation in liver-secreted glycoproteins
-
Pompach P, Ashline DJ, Brnakova Z, et al. Protein and site specificity of fucosylation in liver-secreted glycoproteins. J Proteome Res 2014; 13: 5561–5569. doi: 10.1021/pr5005482
-
(2014)
J Proteome Res
, vol.13
, pp. 5561-5569
-
-
Pompach, P.1
Ashline, D.J.2
Brnakova, Z.3
-
81
-
-
61849124770
-
Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma
-
Comunale MA, Wang M, Hafner J, et al. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res 2009; 8: 595-602. doi: 10.1021/pr800752c
-
(2009)
J Proteome Res
, vol.8
, pp. 595-602
-
-
Comunale, M.A.1
Wang, M.2
Hafner, J.3
-
82
-
-
32444436394
-
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma
-
Comunale MA, Lowman M, Long RE, et al. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 2006; 5: 308-315. doi: 10.1021/pr050328x
-
(2006)
J Proteome Res
, vol.5
, pp. 308-315
-
-
Comunale, M.A.1
Lowman, M.2
Long, R.E.3
-
83
-
-
84870257371
-
Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma
-
Kobayashi, S, Nouso K, Kinugasa H, et al. Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma. Hepatol Res 2012; 42: 1187-1195. doi: 10.1111/j.1872034X.2012.01044.x
-
(2012)
Hepatol Res
, vol.42
, pp. 1187-1195
-
-
Kobayashi, S.1
Nouso, K.2
Kinugasa, H.3
-
84
-
-
0034893110
-
Glypicans: Proteoglycans with a surprise
-
Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001; 108: 497-501. doi: 10.1172/JCI13712
-
(2001)
J Clin Invest
, vol.108
, pp. 497-501
-
-
Filmus, J.1
Selleck, S.B.2
-
85
-
-
22244464888
-
Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma
-
Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 2004; 8: 207-212. doi: 10.1007/BF03260065
-
(2004)
Mol Diagn
, vol.8
, pp. 207-212
-
-
Filmus, J.1
Capurro, M.2
-
86
-
-
73449108795
-
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from nonmalignant chronic liver disease and other liver cancers
-
Tangkijvanich P, Chanmee T, Komtong, S, et al. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from nonmalignant chronic liver disease and other liver cancers. J Gastroenterol Hepatol 2010; 25: 129-137. doi: 10.1111/j.1440-1746.2009.05988.x
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 129-137
-
-
Tangkijvanich, P.1
Chanmee, T.2
Komtong, S.3
-
87
-
-
11144357785
-
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for earlystage hepatocellular carcinoma
-
Hippo Y, Watanabe K, Watanabe A, et al. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for earlystage hepatocellular carcinoma. Cancer Res 2004; 64: 2418-2423. doi: 10.1158/0008-5472.CAN-03-2191
-
(2004)
Cancer Res
, vol.64
, pp. 2418-2423
-
-
Hippo, Y.1
Watanabe, K.2
Watanabe, A.3
-
88
-
-
47649102850
-
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
-
Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta 2008; 395: 19-26. doi: 10.1016/j.cca.2008.05.010
-
(2008)
Clin Chim Acta
, vol.395
, pp. 19-26
-
-
Debruyne, E.N.1
Delanghe, J.R.2
-
89
-
-
66149180568
-
An Akt/hypoxia-inducible factor-1a/ platelet-derived growth factor-BB autocrine loop mediates hypoxiainduced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells
-
Lau CK, Yang ZF, Ho DW, et al. An Akt/hypoxia-inducible factor-1a/ platelet-derived growth factor-BB autocrine loop mediates hypoxiainduced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res 2009; 15: 3462-3471. doi: 10.1158/1078-0432.CCR-08-2127
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3462-3471
-
-
Lau, C.K.1
Yang, Z.F.2
Ho, D.W.3
-
90
-
-
67649200331
-
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor a chain, eliminates human acute myeloid leukemic stem cells
-
Jin L, Lee EM, Ramshaw HS, et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor a chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 2009; 5: 31-42. doi: 10.1016/j.stem.2009.04.018
-
(2009)
Cell Stem Cell
, vol.5
, pp. 31-42
-
-
Jin, L.1
Lee, E.M.2
Ramshaw, H.S.3
-
91
-
-
28444449497
-
Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin
-
Wang SN, Deng YH, Xu H, Wu HB, Qiu YK, Chen DW. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm 2006; 62: 32-38. doi: 10.1016/j.ejpb.2005.07.004
-
(2006)
Eur J Pharm Biopharm
, vol.62
, pp. 32-38
-
-
Wang, S.N.1
Deng, Y.H.2
Xu, H.3
Wu, H.B.4
Qiu, Y.K.5
Chen, D.W.6
-
92
-
-
77954816831
-
Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin
-
Jain NK, Jain SK. Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin. AAPS PharmSciTech 2010; 11: 686-697. doi: 10.1208/ s12249-010-9422-z
-
(2010)
AAPS Pharmscitech
, vol.11
, pp. 686-697
-
-
Jain, N.K.1
Jain, S.K.2
-
93
-
-
54049157140
-
The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma
-
Xu Z, Chen L, Gu W, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009; 30: 226-232. doi: 10.1016/j.biomaterials.2008.09.014
-
(2009)
Biomaterials
, vol.30
, pp. 226-232
-
-
Xu, Z.1
Chen, L.2
Gu, W.3
-
94
-
-
84865216743
-
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma
-
Varshosaz J, Hassanzadeh F, Sadeghi H, Khadem M. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma. J Liposome Res 2012; 22: 224-236. doi: 10.3109/08982104.2012.662653
-
(2012)
J Liposome Res
, vol.22
, pp. 224-236
-
-
Varshosaz, J.1
Hassanzadeh, F.2
Sadeghi, H.3
Khadem, M.4
-
95
-
-
39649087606
-
Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil
-
Zhang C, Cheng Y, Qu G, et al. Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil. Carbohydr Polym 2008; 72: 390-397. doi: 10.1016/j. carbpol.2007.09.004
-
(2008)
Carbohydr Polym
, vol.72
, pp. 390-397
-
-
Zhang, C.1
Cheng, Y.2
Qu, G.3
|